Skip to Main Content

For further information, see CMDT Part 34-08: Adenovirus Infections

KEY FEATURES

  • At least 88 serotypes across seven species (classified A–G), which produce a variety of clinical syndromes

  • Usually self-limited or clinically inapparent except in immunocompromised persons, including

    • People living with HIV infection

    • People with COPD

    • Patients who have undergone solid organ and hematopoietic stem cell transplantation or cardiac surgery

    • People who have received cancer chemotherapy

CLINICAL FINDINGS

  • Incubation period: 4–9 days

  • Viral or bacterial coinfections occur in 15–20% of cases

  • Clinical syndromes often overlap

    • Common cold

    • Nonstreptococcal exudative pharyngitis

    • Lower respiratory tract infections

    • Acute respiratory disease and atypical pneumonia

    • Pharyngoconjunctival fever

    • Epidemic keratoconjunctivitis

    • Acute hemorrhagic cystitis

    • Sexually transmitted genitourinary ulcers and urethritis

    • Acute gastroenteritis, mesenteric adenitis, acute appendicitis, rhabdomyolysis, and intussusception

    • Rarely associated with encephalitis, meningitis, cerebellitis, acute respiratory distress syndrome, acute flaccid myelitis, and pericarditis

  • Risk factors associated with severity of infection

    • Youth

    • Chronic underlying infections

    • Recent transplantation

    • Serotypes 5 or 21

  • Hepatitis (C5 adenovirus), pneumonia, and hemorrhagic cystitis (species B, types 11 and 34) tend to develop in infected liver, lung, or kidney transplant recipients, respectively

  • Disease states that may develop in patients receiving hematopoietic stem cell transplant include

    • Hepatitis

    • Pneumonia

    • Diarrhea

    • Hemorrhagic cystitis

    • Tubulointerstitial nephritis

    • Colitis

    • Encephalitis

DIAGNOSIS

  • Viral culture is considered the standard

    • Antigen detection assays (eg, direct fluorescence assay, enzyme immunoassay) are rapid and show sensitivity of 40–60% compared with viral culture

    • Samples with negative rapid assays require polymerase chain reaction (PCR) assays or viral cultures for diagnosis

  • Quantitative real-time rapid-cycle PCR useful in distinguishing disease from colonization, especially in patients who have received hematopoietic stem cell transplants

  • Multiplex nucleic acid amplification assays can test for multiple respiratory viruses simultaneously with increased sensitivity

  • Appears as a multifocal consolidation or ground-glass opacity without airway inflammatory findings on chest CT imaging

TREATMENT

  • Treatment is symptomatic

  • Ribavirin or cidofovir

    • Used in immunocompromised patients with occasional success

    • Cidofovir is attendant with significant renal toxicity

  • Brincidofovir

    • Lipid-conjugated prodrug of cidofovir

    • Has better oral bioavailability, is better tolerated, and achieves higher intracellular concentrations of active drug than cidofovir

    • Only available through compassionate use policies

  • Intravenous immunoglobulin (IVIG) is used in immunocompromised persons, but data are still limited

  • Topical steroids or tacrolimus may be used to treat adenoviral keratoconjunctivitis

  • The commercially available synthetic corticosteroid mifepristone shows some in vitro activity against adenoviruses

  • Epidemic adenoviral conjunctivitis is often difficult to control and requires

    • Meticulous attention to hand hygiene

    • Use of disposable gloves

    • Sterilization of equipment (isopropyl alcohol is insufficient, recommendations of manufacturers are preferred)

    • Cohorting of cases

    • Furloughing of employees

    • A combination of povidone-iodine 1.0% eyedrops and dexamethasone 0.1% eyedrops four times a day can reduce symptoms and expedite recovery

  • Vaccines are not available for general use

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.

  • Create a Free Profile